image
Spero Therapeutics, Inc. SPRO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.33
-4.44 %
$ 130 M
Market Cap
-1.85
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
40.38%
EBIT Estimate
--1.36%
Net Income Estimate
19.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Spero Therapeutics, Inc.
image
SPRO has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart SPRO

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart SPRO

image
$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart SPRO

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029